E. Musgrove

Oncology · 2009–2017

A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom E. Musgrove trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Shapiro
  2. David M. Sabatini
  3. Marcos Malumbres
  4. Mitchell Dowsett

Papers from E. Musgrove's perspective

Ordered by how strongly the researchers E. Musgrove trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Specific protection against breast cancers by cyclin D1 ablation (Nature)
  2. Concordance among gene-expression-based predictors for breast cancer. (New England Journal of Medicine)
  3. Breast cancer classification and prognosis based on gene expression profiles from a population-based study (Proceedings of the National Academy of Sciences of the United States of America)
  4. Mouse development and cell proliferation in the absence of D-cyclins. (Cell)
  5. Cyclin-dependent kinase pathways as targets for cancer treatment. (Journal of Clinical Oncology)
  6. Living with or without cyclins and cyclin-dependent kinases. (Genes & Development)
  7. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. (Journal of the National Cancer Institute)
  8. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. (Journal of the National Cancer Institute)
  9. Hallmarks of cancer: the next generation. (Cell)
  10. Cell cycle, CDKs and cancer: a changing paradigm (Nature Reviews. Cancer)

Their papers